Fingerprint
Dive into the research topics of 'Cost-effectiveness of Bezlotoxumab Compared with Placebo for the Prevention of Recurrent Clostridium difficile Infection'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Cost-effectiveness of Bezlotoxumab Compared with Placebo for the Prevention of Recurrent Clostridium difficile Infection
Vimalanand S. Prabhu, Erik R. Dubberke, Mary Beth Dorr, Elamin Elbasha, Nicole Cossrow, Yiling Jiang, Stephen Marcella
Research output: Contribution to journal › Article › peer-review
43
Scopus
citations